Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Clonidine

Clonidine
In stock
0,1mg
from 30,57 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
36,69 £30,57 £
0,51 £ per tablet

In brief

  • In our pharmacy, you can buy clonidine without a prescription, with delivery in 9–21 days throughout the United Kingdom. Discreet and anonymous packaging.
  • Clonidine is used for hypertension, off-label for ADHD (specialist use) and for symptoms of withdrawal, and as an injection in specialist pain management; it is a central alpha‑2 adrenergic agonist and imidazoline receptor agonist that reduces sympathetic outflow to lower blood pressure and heart rate.
  • The usual dose for adults with hypertension is 0.1 mg twice daily, titrated by 0.1 mg every 1–2 weeks (maximum 1.2 mg/day); off-label ADHD dosing often starts at 0.1 mg at night and may be increased weekly (up to ~0.4 mg/day divided).
  • In the UK, clonidine is available as oral tablets and as an injection for hospital use.
  • Onset: oral effects typically begin within 30–60 minutes (peak 1–3 hours); injectable onset is more rapid (minutes).
  • Duration of action varies by formulation: oral doses last roughly 6–12 hours; continuous infusions act while administered.
  • Alcohol warning: avoid or limit alcohol—concurrent alcohol increases drowsiness, sedation and the risk of marked hypotension and respiratory depression.
  • The most common side effect is dry mouth.
  • Would you like to try clonidine without a prescription?

Basic clonidine information

  • INN (international nonproprietary name): Clonidine.
  • Brand names available in the United Kingdom: Catapres; generic clonidine tablets.
  • ATC code: C02AC01 (antihypertensives, imidazoline receptor agonists).
  • Forms and dosages: Tablets 25 mcg and 100 mcg; injection (hospital use).
  • Manufacturers in the United Kingdom: Various generic manufacturers.
  • Registration status in the United Kingdom: Licensed; prescription-only medicine (POM).
  • OTC / Rx classification: Prescription-only medicine (POM).

Critical warnings and restrictions

High‑risk groups (elderly, pregnancy, chronic illness)

Clonidine can cause marked sedation, hypotension and bradycardia, which are clinically significant risks for vulnerable patients.

Absolute contraindications include hypersensitivity to clonidine and severe bradyarrhythmia or advanced AV block in patients without a pacemaker.

Relative concerns include renal impairment, significant coronary artery disease, severe hepatic impairment and a history of depression, all of which need closer monitoring and dose adjustment.

Pregnancy requires specialist review because risks and benefits vary; maternal blood‑pressure control and foetal safety must be weighed using local guidance.

Breastfeeding mothers need individual assessment because clonidine passes into breast milk and may sedate the infant.

Elderly patients should start at lower doses, for example 0.05 mg twice daily, and be titrated slowly with home blood‑pressure monitoring to reduce falls and orthostatic events.

Use this pre‑treatment checklist before initiation.

  • Baseline blood pressure and heart rate measurement.
  • ECG if there is a history or suspicion of bradyarrhythmia or conduction disease.
  • Renal and liver function tests where indicated.
  • Full medication reconciliation to identify additive effects with other CNS depressants or antihypertensives.
  • Falls risk assessment, especially in older adults and those with balance problems.

Interaction with activities (driving, workplace safety under UK law)

Clonidine commonly causes sedation and dizziness, which can impair driving and the safe use of machinery.

Under UK rules patients must ensure they are fit to drive and must not drive if their concentration, alertness or coordination are affected.

If clonidine affects driving ability the patient should discuss dose timing or alternatives with their GP or pharmacist and may need to inform the DVLA.

Q&A — “Can I drive after taking it in the UK?”

There is no guarantee you can drive safely after taking clonidine; if you feel drowsy, dizzy or less alert do not drive.

UK guidance requires drivers to remain safe; inform the DVLA if treatment affects concentration or alertness as this can affect driving licence duties.

Discuss timing of doses with your GP or pharmacist — taking the main dose at night can reduce daytime sleepiness for some patients.

Usage basics

INN, brand names available in the UK

The International Nonproprietary Name is clonidine.

In UK practice the common brand is Catapres, plus generic clonidine tablets (25 mcg and 100 mcg) from various suppliers.

Legal classification (POM, P, GSL)

Clonidine is a prescription-only medicine (POM) in the UK and is regulated by the MHRA.

It is dispensed via NHS prescriptions or private prescriptions, and electronic prescribing is commonly used in general practice.

Form Common strengths Legal status
Tablet 25 mcg – 100 mcg Prescription-only medicine (POM)
Injection (hospital use) Specialist use Prescription-only medicine (POM)

Dosing guide

Standard regimens (NHS guidelines)

For adults with hypertension, oral initiation is typically 0.1 mg twice daily with titration by 0.1 mg every 1–2 weeks up to clinical response; the BNF maximum is 1.2 mg daily.

For ADHD (off-label, specialist use), initiation is often 0.1 mg at night with weekly increments as tolerated.

In acute opioid or alcohol withdrawal settings short regimens use 0.1–0.2 mg every 4–6 hours to control autonomic symptoms, under supervision.

Injectable clonidine is used in specialist pain management, titrated to effect in a specialist setting.

Adjustments for comorbidities

Children start low for ADHD, commonly 0.05–0.1 mg at night, and dose is adjusted by response while avoiding abrupt cessation.

Elderly patients should begin at lower doses such as 0.05 mg twice daily with slow titration and monitoring for orthostatic hypotension.

In renal impairment dose reductions are advised because clonidine is partly renally excreted and CNS depression risk increases.

In hepatic impairment use clonidine with caution and monitor clinically due to hepatic metabolism.

Q&A — “What if I miss a dose?”

If you miss a tablet dose, take it as soon as you remember unless your next dose is near, in which case skip the missed dose.

Do not double up doses to make up for a missed tablet.

  • Titration steps: Start 0.1 mg BID for adults, increase by 0.1 mg every 1–2 weeks to response; elderly start 0.05 mg BID and titrate slowly.
  • Monitoring checklist: Regular BP/HR checks during titration, watch for sedation, assess falls risk and record any new symptoms.

Interaction chart

Food and drinks (alcohol, tea/coffee, diet habits)

Alcohol potentiates central nervous system depression and hypotension with clonidine, so advise patients to avoid or limit alcohol while taking the medicine.

Caffeine may mask some sedative effects but does not prevent hypotension and is not a substitute for monitoring symptoms.

No major food–drug interactions are recorded, but maintain consistent meal patterns to reduce orthostatic symptoms when standing up.

Common drug conflicts

Use extra caution with other antihypertensives due to additive hypotensive effects.

Beta‑blockers and calcium‑channel blockers may increase risk of bradycardia and conduction abnormalities when combined with clonidine.

Sedative medicines including hypnotics and opioids can increase sedation and respiratory depression risk when used together with clonidine.

Tricyclic antidepressants and MAO inhibitors have complex interactions and warrant specialist advice.

Abrupt withdrawal of clonidine can interact with other agents by provoking a sympathetic surge and rebound hypertension.

Concomitant drug Interaction mechanism Clinical risk Action
Other antihypertensives Additive hypotensive effect Dizziness, syncope Monitor BP; adjust doses
Beta‑blockers / CCBs Synergistic bradycardia or conduction slowing Bradycardia, heart block ECG and monitor HR; avoid where severe conduction disease
Opioids / sedatives / alcohol Increased CNS depression Excess sedation, respiratory depression Avoid or monitor closely; counsel on driving
Tricyclic antidepressants / MAOIs Complex central interactions Variable BP and CNS effects Specialist review and monitoring
  • Drugs needing extra monitoring: Beta‑blockers, methyldopa, guanfacine and other central agents.

Legal status and availability in the UK

In our online pharmacy, clonidine is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Mechanism and pharmacology

Simplified explanation

Clonidine is a centrally acting alpha‑2 adrenergic agonist that reduces sympathetic outflow from the brainstem, lowering peripheral vascular resistance and heart rate.

This mechanism reduces blood pressure and attenuates the sympathetic overactivity seen in opioid or alcohol withdrawal.

Clonidine also acts at imidazoline receptors, which contributes to its antihypertensive effects and explains its ATC classification C02AC01.

Clinical terms

Injectable clonidine yields an immediate effect and is used in specialist acute or epidural settings.

Clonidine undergoes hepatic metabolism with partial renal excretion, so dose adjustments are required in renal impairment and caution is advised in hepatic disease.

Alpha‑2 agonist
An agent that reduces sympathetic tone via central alpha‑2 receptors.
Imidazoline receptor
A receptor subtype implicated in central blood‑pressure regulation.
Formulation Typical onset Typical duration
Tablet 30–60 minutes 6–12 hours
Injection Minutes Variable, dependent on infusion/titration

Indications and off‑label uses

MHRA‑approved uses

In the UK, clonidine tablets are licensed for hypertension, and low-dose (25 mcg) tablets for migraine prophylaxis and menopausal flushing; use in ADHD is off-label and specialist-led, and injectable clonidine is used by specialist teams in pain management.

Off‑label practices in NHS and private care

Common off‑label uses in UK practice include management of opioid and alcohol withdrawal symptoms and ADHD under specialist supervision.

Specialist pain clinics may use injectable clonidine as part of multimodal analgesia.

Off‑label use should be documented with informed consent and a clear rationale recorded in the clinical notes.

  • Prescriber checklist: state the indication, summarise the evidence, list alternative options, obtain informed consent, set a monitoring plan and report adverse events appropriately.

Dosing examples for indications:

  • Hypertension (adults): Start 0.1 mg twice daily, titrate by 0.1 mg every 1–2 weeks to response.
  • ADHD (off-label, specialist use): Start 0.1 mg at night, increase weekly as tolerated.
  • Withdrawal support: 0.1–0.2 mg every 4–6 hours in supervised settings.

Alternatives matrix

NHS prescribing alternatives (comparison table)

Drug / class Typical clinical role Key advantages Key risks / monitoring Suitability vs clonidine
ACE inhibitors (ramipril, enalapril) First‑line for many patients with hypertension Proven cardiovascular benefit in many groups Monitor renal function and potassium Preferable unless contraindicated; clonidine reserved when others unsuitable
ARBs Alternative to ACE inhibitors Less cough than ACE inhibitors Monitor renal function Often preferred to clonidine for long‑term management
Calcium‑channel blockers First‑line for older patients Effective in isolated systolic hypertension Monitor for peripheral oedema Usually tried before clonidine
Methyldopa Pregnancy‑friendly antihypertensive Safe in pregnancy in many cases Sedation, liver function monitoring May be favoured in pregnancy over clonidine
Guanfacine ADHD alternative Similar central action, different side‑effect profile Monitor BP/HR Consider when clonidine causes intolerable sedation

Pros and cons checklist

Pros of clonidine: effective central antihypertensive mechanism, useful in withdrawal symptom control.

Cons of clonidine: sedation is common, risk of rebound hypertension on abrupt cessation and renal dose adjustments required.

  • Patient scenarios favouring clonidine: intolerance to ACE inhibitors, symptomatic autonomic withdrawal control under supervision.

Common questions

Will clonidine make me sleepy all day?

Daytime sedation is common; consider night dosing or slow titration and discuss with your GP or pharmacist before driving.

Can I stop clonidine suddenly?

No; abrupt discontinuation can provoke rebound hypertension and a sympathetic surge, so taper slowly under clinician supervision.

Is clonidine safe in pregnancy?

Pregnancy requires specialist input and alternatives are often preferred; document risks and benefits clearly when prescribing.

  • When to call GP/999: syncope, severe bradycardia, breathing difficulties or signs of severe allergic reaction.
  • When to report side effects: report via the MHRA Yellow Card scheme for suspected adverse reactions.

Registration and regulation

MHRA approval process

Clonidine products on the UK market are authorised by the MHRA and clinicians should consult the product licence (SmPC) for licensed indications, contraindications and monitoring requirements.

Adverse reactions should be reported through the MHRA Yellow Card scheme to support post‑marketing surveillance.

NHS prescribing framework

Prescribing clonidine on the NHS follows local formulary guidance and any applicable NICE recommendations.

Electronic prescriptions and repeat prescribing must include a monitoring plan for blood pressure and heart rate, clear titration and stopping instructions.

  • Prescriber checklist: check the SmPC, document indication, record consent for off‑label use, specify monitoring intervals, list interactions and warn about withdrawal risks.
  • Reporting routes: MHRA Yellow Card for adverse events and local governance for formulary exceptions.

Storage and handling

UK household storage (cold/damp climate)

Tablets should be stored at room temperature, protected from moisture, typically 15–30°C.

Given the UK’s variable humidity avoid storing tablets in bathrooms or near sinks where moisture can degrade the product.

Keep all medicines out of reach of children and pets and in original packaging to avoid confusion.

Guidance from NHS and pharmacists

Return unused or expired tablets to a pharmacy for safe disposal.

Travel advice: carry medication in original packaging with prescription details and avoid extreme temperatures during flights or in checked luggage.

Guidelines for proper use

UK pharmacist counselling style

Adopt a safety‑first counselling approach: confirm the indication and explain how to take the tablets correctly.

Warn about possible sedation and the impact on driving, advise on alcohol avoidance and explain the risk of rebound hypertension on abrupt cessation.

Provide clear monitoring advice for BP and heart rate and give written information signposting to NHS.uk leaflets.

NHS patient safety advice

Practical safety checklist for patients includes carrying a list of medications, measuring blood pressure regularly during titration and avoiding sudden stopping without advice.

Report severe dizziness, syncope, breathing difficulties or very low heart rate to the GP or emergency services immediately.

For children on ADHD regimens liaise with the school about dosing times, watch for changes in sleep and appetite and discuss dose timing with the prescriber.

  • Short handout: when to contact GP, when to attend A&E, how to report side effects via the Yellow Card and how to contact the pharmacy for minor queries.

Delivery across the United Kingdom

City Region Delivery Time
London Greater London 9–21 days
Birmingham West Midlands 9–21 days
Manchester Greater Manchester 9–21 days
Glasgow Scotland 9–21 days
Cardiff Wales 9–21 days
Belfast Northern Ireland 9–21 days
Leeds West Yorkshire 9–21 days
Newcastle Tyne and Wear 9–21 days
Southampton South East England 9–21 days
Plymouth South West England 9–21 days
Norwich East of England 9–21 days
Exeter South West England 9–21 days
Oxford South East England 9–21 days
Lancaster North West England 9–21 days

Final notes

Clonidine is a useful centrally acting medicine with multiple formulations and clinical roles, but it requires careful patient selection and monitoring because of sedation, hypotension and withdrawal risks.

Pharmacists should ensure patients receive clear verbal and written advice about dosing, driving, alcohol and how to report adverse effects via the MHRA Yellow Card.

Always consult the SmPC for the specific product being supplied and document off‑label use, monitoring plans and consent where appropriate.

Related products